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Introduction
Despite FMF is considered an autosomal recessive dis-
ease caused by mutations of MEFV, one third of patients
carries one mutation only.
Aim
To analyze the actual impact of MEFV mutations in
children with periodic fever.
Methods
113 caucasian patients carrying MEFV mutations (46 with
mutations in two alleles, 67 heterozygous) and 205 geneti-
cally negative patients for MEFV, TNFSF1A and MEFV
(70% with a PFAPA phenotype) were analyzed. The fol-
lowing groups were considerd: patients with: i) 2 high
penetrance mutations (M694V, M694I, M680I), ii) 1 high,
1 low penetrance mutation, iii) 2 low penetrance muta-
tions, iv) 1 high penetrance mutation, v) one low pene-
trance mutation, vi) genetically negative.
Results
Patients with two mutations displayed a higher preva-
lence of chest pain (p = 0.001), pleurisy (p = 0.003) and
severe abdominal pain (p = 0.002) in respect to hetero-
zygous patients, which clinical phenotype was more
similar to that presented by genetically negative patients,
with an higher prevalence of erythematous (p = 0.01)
and exudative ( p = 0.009) pharyngitis, enlarged cervical
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Figure 1 Prevalence of the clincial manifestations associated to fever attacks in patients with different MEFV genotypes (see text) and in patients
with periodic fever negative for mutations of MEFV, MVK and TNFSRF1A genes. P values were assessed by a Chi-square test for trend.
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symptoms” decreases from patients carrying two high
penetrance mutations towards patients with a single low
penetrance mutation with a specular increase of
“PFAPA-like symptoms” (Figure 1).
Conclusions
The present study shows a dosage effect of MEFV muta-
tions not consistent with a pure autosomal recessive dis-
order. A dominant negative or gain of function effects
or variants of still unidentified modifier genes may influ-
ence the presence of a FMF phenotype in heterozygous
patients.
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